However, E-cadherin was at lower levels in highly differentiated prostate tumors, along with the absence of CXCR3-B on the membrane and reduced cytoplasmic levels (Fig. 7a and b, second panel). The gene discussed is CDH1; the disease is prostate neoplasm.